Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ASP-3026 shows antitumor activity in murine model of NSCLC

April 15, 2011

Carbamate-based NCEH inhibitor AX-13057 shows promising potency

April 15, 2011

EMD-1204831 shows antitumor activity in preclinical studies

April 15, 2011

4SC grants Yakult Honsha license to resminostat in Japan

April 14, 2011

Myriad Genetics to conduct mutation testing for BioMarin's phase I/II BMN-673 trial

April 14, 2011

New 17-beta-HSD 3 inhibitors prepared by Sumitomo

April 14, 2011

Pfizer's new HSP 90 inhibitor PF-4942847 shows promise in triple-negative breast cancer in vivo

April 14, 2011

First-in-human data reported on GDC-0973 alone and in combination with GDC-0941

April 14, 2011

PharmaMar begins phase II Yondelis trial in advanced breast cancer

April 13, 2011

Immunovaccine reports interim phase I data on anticancer vaccine DPX-0907

April 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...